BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36661917)

  • 1. A Story of PA/BSA and Biomarkers to Diagnose Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis-The Rise of IGF-BP2 and GDF-15.
    Kletzer J; Hecht S; Ramsauer S; Scharinger B; Kaufmann R; Kammler J; Kellermair J; Akbari K; Blessberger H; Steinwender C; Hergan K; Hoppe UC; Lichtenauer M; Boxhammer E
    J Cardiovasc Dev Dis; 2023 Jan; 10(1):. PubMed ID: 36661917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Main pulmonary artery diameter in combination with cardiovascular biomarkers: new possibilities to identify pulmonary hypertension in patients with severe aortic valve stenosis.
    Boxhammer E; Paar V; Jirak P; Köller C; Demirel O; Eder S; Reiter C; Kammler J; Kellermair J; Hammerer M; Blessberger H; Steinwender C; Hoppe UC; Lichtenauer M
    Minerva Med; 2023 Dec; 114(6):802-814. PubMed ID: 35822856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT measured pulmonary artery to ascending aorta ratio stratified by echocardiographically obtained systolic pulmonary artery pressure values for noninvasive detection of pulmonary hypertension in patients with severe aortic valve stenosis.
    Boxhammer E; Kletzer J; Kellermair J; Scharinger B; Kaufmann R; Hammerer M; Blessberger H; Steinwender C; Lichtenauer M; Hergan K; Hoppe UC; Hecht S
    Clin Res Cardiol; 2023 Oct; 112(10):1394-1416. PubMed ID: 36935421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-Diagnosed Sarcopenia and Cardiovascular Biomarkers in Patients Undergoing Transcatheter Aortic Valve Replacement: Is It Possible to Predict Muscle Loss Based on Laboratory Tests?-A Multicentric Retrospective Analysis.
    Hecht S; Boxhammer E; Kaufmann R; Scharinger B; Reiter C; Kammler J; Kellermair J; Hammerer M; Blessberger H; Steinwender C; Hoppe UC; Hergan K; Lichtenauer M
    J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparability between Computed Tomography Morphological Vascular Parameters and Echocardiography for the Assessment of Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis-Results of a Multi-Center Study.
    Boxhammer E; Scharinger B; Kaufmann R; Brandtner H; Schmidbauer L; Kammler J; Kellermair J; Reiter C; Akbari K; Hammerer M; Blessberger H; Steinwender C; Hergan K; Hoppe UC; Lichtenauer M; Hecht S
    Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36292052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiological Parameters for the Detection of Pulmonary Hypertension in Severe Aortic Valve Stenosis and Their Influence on Mortality: Does Sex Matter?
    Kletzer J; Scharinger B; Demirel O; Kaufmann R; Medved M; Reiter C; Hammerer M; Steinwender C; Hecht S; Kopp K; Hoppe UC; Hergan K; Boxhammer E
    J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610764
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH).
    Mirna M; Rohm I; Jirak P; Wernly B; Bäz L; Paar V; Kretzschmar D; Hoppe UC; Schulze PC; Lichtenauer M; Jung C; Franz M
    Heart Lung Circ; 2020 Mar; 29(3):337-344. PubMed ID: 31327702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Presence of Ascending Aortic Dilatation in Patients Undergoing Transcatheter Aortic Valve Replacement Is Negatively Correlated with the Presence of Diabetes Mellitus and Does Not Impair Post-Procedural Outcomes.
    Boxhammer E; Hecht S; Kaufmann R; Kammler J; Kellermair J; Reiter C; Akbari K; Blessberger H; Steinwender C; Lichtenauer M; Hoppe UC; Hergan K; Scharinger B
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline PA/BSA ratio in patients undergoing transcatheter aortic valve replacement - A novel CT-based marker for the prediction of pulmonary hypertension and outcome.
    Sudo M; Sugiura A; Treiling L; Al-Kassou B; Shamekhi J; Kütting D; Wilde N; Weber M; Zimmer S; Nickenig G; Sedaghat A
    Int J Cardiol; 2022 Feb; 348():26-32. PubMed ID: 34923001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
    Boxhammer E; Mirna M; Bäz L; Bacher N; Topf A; Sipos B; Franz M; Kretzschmar D; Hoppe UC; Lauten A; Lichtenauer M
    Life (Basel); 2022 Mar; 12(3):. PubMed ID: 35330140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of novel cardiovascular biomarkers in patients with chronic heart failure.
    Lichtenauer M; Jirak P; Wernly B; Paar V; Rohm I; Jung C; Schernthaner C; Kraus J; Motloch LJ; Yilmaz A; Hoppe UC; Christian Schulze P; Kretzschmar D; Pistulli R
    Eur J Intern Med; 2017 Oct; 44():31-38. PubMed ID: 28579310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the serum GDF-15 concentration and muscle function in female patients receiving aortic valve replacement (TAVR, SAVR): Comparison with healthy elderly female subjects.
    Fukuda T; Nakajima T; Yazawa H; Hirose S; Yokomachi J; Kato T; Nishikawa R; Koshiji N; Tokura M; Nasuno T; Nishino S; Obi S; Shibasaki I; Kanaya T; Nakamura F; Fukuda H; Abe S; Sakuma M; Toyoda S
    Int J Cardiol Heart Vasc; 2022 Jun; 40():101032. PubMed ID: 35495578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Left Ventricular Diastolic Dysfunction and Biomarkers on Pulmonary Hypertension in Patients with Severe Aortic Stenosis.
    Gumauskienė B; Krivickienė A; Jonkaitienė R; Vaškelytė JJ; Siudikas A; Ereminienė E
    Medicina (Kaunas); 2018 Sep; 54(4):. PubMed ID: 30344294
    [No Abstract]   [Full Text] [Related]  

  • 14. Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure.
    Jirak P; Fejzic D; Paar V; Wernly B; Pistulli R; Rohm I; Jung C; Hoppe UC; Schulze PC; Lichtenauer M; Yilmaz A; Kretzschmar D
    Acta Pharmacol Sin; 2018 Jul; 39(7):1189-1196. PubMed ID: 29239349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and impact of pulmonary hypertension on patients with aortic stenosis who underwent transcatheter aortic valve replacement.
    Barbash IM; Escarcega RO; Minha S; Ben-Dor I; Torguson R; Goldstein SA; Wang Z; Okubagzi P; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2015 May; 115(10):1435-42. PubMed ID: 25776456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis.
    Ben-Dor I; Minha S; Barbash IM; Aly O; Dvir D; Deksissa T; Okubagzi P; Torguson R; Lindsay J; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2013 Aug; 112(4):574-9. PubMed ID: 23683951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Boxhammer E; Berezin AE; Paar V; Bacher N; Topf A; Pavlov S; Hoppe UC; Lichtenauer M
    J Pers Med; 2022 Apr; 12(4):. PubMed ID: 35455719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel cardiovascular biomarkers in patients with cardiovascular diseases undergoing intensive physical exercise.
    Mirna M; Lichtenauer M; Wernly B; Paar V; Jung C; Kretzschmar D; Uhlemann M; Franz M; Hoppe UC; Schulze PC; Hilberg T; Adams V; Sponder M; Möbius-Winkler S
    Panminerva Med; 2020 Sep; 62(3):135-142. PubMed ID: 32309918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry.
    Chen S; Redfors B; O'Neill BP; Clavel MA; Pibarot P; Elmariah S; Nazif T; Crowley A; Ben-Yehuda O; Finn MT; Alu MC; Vahl TP; Kodali S; Leon MB; Lindman BR
    Eur Heart J; 2020 Feb; 41(8):958-969. PubMed ID: 31883339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Natriuretic Peptide Levels After Transcatheter Aortic Valve Replacement With Subsequent Clinical Outcomes.
    O'Leary JM; Clavel MA; Chen S; Goel K; O'Neill B; Elmariah S; Crowley A; Alu MC; Thourani VH; Leon MB; Pibarot P; Lindman BR
    JAMA Cardiol; 2020 Oct; 5(10):1113-1123. PubMed ID: 32667623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.